The invention involves administration of an imidazoquinoline agent in combination with another therapeutic agent. A gate insulating layer and a passivation layer are formed by printing organic insulating material in order to simplify the fabricating process. The cooling jacket may be formed of a ceramic material and preferably is of a monolithic construction. % hydrophobic polyols, 2 to 65 wt.